ELVN
Enliven Therapeutics, Inc. Common Stock ยท Health Care ยท NASDAQ
$45.96
โฒ $0.86 (+1.91%)
Market cap
$3.1B
52-week range
$14.79 โ $48.53
Volume
2.5M
Previous close
$45.10
Enliven Therapeutics, Inc. Common Stock (ELVN) is held by 4 tracked hedge fund(s). Sector: Health Care. Largest tracked holder: ORBIMED ADVISORS LLC.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC ORBIMED ADVISORS LLC |
6.2% | 8.0M | $312M | โ | $21.90 | 2026-03-31 |
| Polar Capital Holdings Plc Polar Capital Holdings Plc |
0.7% | 5.1M | $199M | โฒ 44% (+1.6M) | $23.37 | 2026-03-31 |
| BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP |
0.2% | 905K | $35M | โฒ 234% (+634K) | $17.59 | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC VANGUARD PORTFOLIO MANAGEMENT LLC |
0.1% | 331K | $13M | NEW (+331K) | $39.20 | 2026-03-31 |
FAQ โพ
Which hedge funds hold ELVN?
Tracked holders include: ORBIMED ADVISORS LLC, Polar Capital Holdings Plc, BAKER BROS. ADVISORS LP, VANGUARD PORTFOLIO MANAGEMENT LLC.
How much smart money owns ELVN?
4 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading ELVN?
No tracked Congressional trades in ELVN on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings ยท Not investment advice โพ
Ownership from SEC filings; price from market data.
Published by WealthFile ยท Not investment advice.